Suono Bio
Sean Moran, CPA, is a Senior Management Advisor at Suono Bio. He has been CFO at Corbus Pharmaceuticals since January 2014. He has more than twenty years of senior financial experience with emerging biotechnology, drug delivery, and medical device companies. Mr. Moran has successfully managed operations from start up through development to commercialization and profitability. He has completed three IPOs and has raised over $200 million of capital. Before joining Corbus, Mr. Moran served as Chief Financial Officer for InVivo Therapeutics, Celsion Corporation, Echo Therapeutics, Sontra Medical, and Anika Therapeutics. Mr. Moran earned his M.B.A. and a B.S. in Accounting from Babson College in Wellesley, MA.
This person is not in any offices
Suono Bio
Suono Bio is developing therapeutic products for inflammatory-mediated diseases leveraging their ultra-rapid and formulation-independent delivery technology. Suono Bio’s platform enables rapid, localized delivery of small molecules, biologics, and nucleic acids, and gene therapies without the need for encapsulation of the therapeutic.